*Current Pharmaceutical Design*, 26(25), 2953-2962
The rationale for blending these two peptides stems from their non-overlapping receptor targets and complementary metabolic effects: Amylin Pathway (Cagrilintide): Targets amylin receptors in the brainstem Creates meal-specific satiety signals Slows gastric emptying through distinct mechanisms Reduces meal size and eating frequency Triple Agonist Pathway (Retatrutide): Activates GIP, GLP-1, and glucagon receptors Enhances insulin secretion and glucose metabolism Increases energy expenditure through glucagon effects Provides broader metabolic regulation When combined, these pathways could theoretically provide additive or synergistic effects on weight management and metabolic function
When you take vitamins orally, your digestive system has to break them down, and only a fraction actually makes it into your bloodstream
While the mechanism of how NAD+ works in this regard is still under investigation, it is believed that IV NAD+ helps flush drugs out of the body and reduce cravings
In metabolic research models, high-fat diets typically lead to hypertrophy (enlargement) of WAT cells and a slowdown in their metabolic rate